Benefits and risks of the Sanofi-Pasteur dengue vaccine: Modeling optimal deployment (Q26746185)

1

object named as

N. M. Ferguson

0 references

author name string

I. Rodriguez-Barraquer

2

0 references

L. Mier-y-Teran-Romero

4

0 references

D. J. Laydon

5

0 references

D. A. T. Cummings

Understanding dengue pathogenesis: implications for vaccine design

6

0 references

language of work or name

English

0 references

publication date

1 September 2016

0 references

1 reference

353

0 references

page(s)

1033-1036

0 references

issue

6303

0 references

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5268127

A prospective study of dengue infections in Bangkok

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5268127

Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity

7 April 2017

1 reference

https://api.crossref.org/works/10.1126/SCIENCE.AAF9590

Dengue virus type 2: replication and tropisms in orally infected Aedes aegypti mosquitoes

22 April 2017

1 reference

https://api.crossref.org/works/10.1126/SCIENCE.AAF9590

Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: a randomised, controlled phase 2b trial

22 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5268127

Research on dengue during World War II

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5268127

Projected Impact of Dengue Vaccination in Yucatán, Mexico

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5268127

Safety and Immunogenicity of a Tetravalent Dengue Vaccine Candidate in Healthy Children and Adults in Dengue-Endemic Regions: A Randomized, Placebo-Controlled Phase 2 Study

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5268127

Public health impact and cost-effectiveness of the RTS,S/AS01 malaria vaccine: a systematic comparison of predictions from four mathematical models

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5268127

Efficacy and Long-Term Safety of a Dengue Vaccine in Regions of Endemic Disease

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5268127

Modelling the immunological response to a tetravalent dengue vaccine from multiple phase-2 trials in Latin America and South East Asia

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5268127

Robust and Balanced Immune Responses to All 4 Dengue Virus Serotypes Following Administration of a Single Dose of a Live Attenuated Tetravalent Dengue Vaccine to Healthy, Flavivirus-Naive Adults

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5268127

Modeling the impact on virus transmission of Wolbachia-mediated blocking of dengue virus infection of Aedes aegypti

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5268127

Efficacy of a tetravalent dengue vaccine in children in Latin America.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5268127

Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: a phase 3, randomised, observer-masked, placebo-controlled trial

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5268127

Immunogenicity and safety of a recombinant tetravalent dengue vaccine in children and adolescents ages 9-16 years in Brazil

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5268127

Safety and immunogenicity of a recombinant tetravalent dengue vaccine in 9-16 year olds: a randomized, controlled, phase II trial in Latin America.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5268127

Challenges in the interpretation of dengue vaccine trial results

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5268127

Reduced risk of disease during postsecondary dengue virus infections

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5268127

Prevention of measles, rubella, congenital rubella syndrome, and mumps, 2013: summary recommendations of the Advisory Committee on Immunization Practices (ACIP).

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5268127

Immunogenicity and safety of recombinant tetravalent dengue vaccine (CYD-TDV) in individuals aged 2-45 y: Phase II randomized controlled trial in Singapore

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5268127

Immunogenicity and safety of tetravalent dengue vaccine in 2-11 year-olds previously vaccinated against yellow fever: randomized, controlled, phase II study in Piura, Peru

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5268127

Live-attenuated, tetravalent dengue vaccine in children, adolescents and adults in a dengue endemic country: randomized controlled phase I trial in the Philippines

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5268127

Immune response to dengue virus and prospects for a vaccine

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5268127

The effects of tertiary and quaternary infections on the epidemiology of dengue

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5268127

A novel tetravalent dengue vaccine is well tolerated and immunogenic against all 4 serotypes in flavivirus-naive adults

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5268127

"Guidelines for the clinical evaluation of dengue vaccines in endemic areas": summary of a World Health Organization Technical Consultation

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5268127

Cross-serotype neutralization of dengue virus in Aotus nancymae monkeys

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5268127

The dengue group of viruses and its family relationships.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5268127

Serotype-specific dengue virus circulation and dengue disease in Bangkok, Thailand from 1973 to 1999.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5268127

Immune enhancement of viral infection

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5268127

Prevention of perinatal transmission of hepatitis B virus: prenatal screening of all pregnant women for hepatitis B surface antigen

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5268127

Dengue vaccine: hypotheses to understand CYD-TDV-induced protection

31 May 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAF9590

Estimation of parameters related to vaccine efficacy and dengue transmission from two large phase III studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAF9590

Interactions between serotypes of dengue highlight epidemiological impact of cross-immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAF9590

An outbreak of primary dengue infection among migrant Chinese workers in Singapore characterized by prominent gastrointestinal symptoms and a high proportion of symptomatic cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAF9590

Host and viral features of human dengue cases shape the population of infected and infectious Aedes aegypti mosquitoes

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAF9590

Cytoplasmic incompatibility in populations with overlapping generations

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAF9590

A stochastic population dynamics model for Aedes aegypti: formulation and application to a city with temperate climate

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAF9590

Longitudinal studies of Aedes aegypti (Diptera: Culicidae) in Thailand and Puerto Rico: blood feeding frequency

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAF9590

The incubation periods of Dengue viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAF9590

Asymptomatic humans transmit dengue virus to mosquitoes

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAF9590

Prospective study of the duration and magnitude of viraemia in children hospitalised during the 1996-1997 dengue-2 outbreak in French Polynesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAF9590

The seasonal pattern of dengue in endemic areas: mathematical models of mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAF9590

Revisiting Rayong: shifting seroprofiles of dengue in Thailand and their implications for transmission and control

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAF9590

Differential efficacy of dengue vaccine by immune status

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/27701113

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Effect of temperature on the vector efficiency of Aedes aegypti for dengue 2 virus

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAF9590